The Sterlington Group

is a boutique investment bank located

in New York City, New York. 

Our practice is primarily targeted towards capital raising, M&A advisory and CFO consulting services

for healthcare and lifesciences companies.

 For over 20 years, Jack has been an investment banker including as Head of Healthcare for three firms. At Catalyst Pharmaceuticals (Nasdaq: CPRX), a specialty pharmaceutical company, Jack was CFO, VP of Business Development and Treasurer. As part of CPRX’s senior management, he in‐licensed two prescription drugs, and raised over $35 million in private and public equity financing, including a full‐blown IPO. Jack brings additional insights based on skills gained as an operator and equity investor. As a General Partner of a private equity fund, he raised capital for the fund, evaluated investments, served as a Board of Director member and actively assisted portfolio companies develop and implement strategic acquisitions and growth plans. As an operating executive, he restructured a division of a healthcare services and consulting company to make it a viable independent entity. Jack earned his MBA from the Harvard Business School, and graduated from the University of Miami with a BM degree, magna cum laude. Jack also holds FINRA Series 79 and 63 Licenses.